Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2019: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Hyperthermia (HT) has been used as mild anticancer therapy. However, HT alone is insufficient to completely kill tumor cells and an additional agent is required to overcome. In the present study, we have screened and identified several natural compounds as an adjunctive therapy to HT to induce cell death. We also explored the molecular mechanisms involved.
|